(Allergan plc)

	AGN latest price $217.2354 (0.74%) ($215.4393 - $218.1675) on Wed. May. 31, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.85% (three month average)
RSI	37
Latest Price	$217.2354(0.74%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -0.9% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(45%)    SPY(44%)    ARKG(43%)
Factors Impacting AGN price	AGN will decline at least -0.425% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-15%)    SHY(-3%)    GDXJ(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.425% (StdDev 0.85%)
Hourly BBV	0 ()
Intraday Trend	0.5%

Resistance Level	$221.31
5 Day Moving Average	$216.99(0.11%)
10 Day Moving Average	$215.23(0.93%)
20 Day Moving Average	$221.31(-1.84%)
To recent high	-8.6%
To recent low	2.3%
Market Cap	$71.623b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed